Literature DB >> 1140851

Effect of temperature on phagocytosis by human polymorphonuclear neutrophils.

G L Mandell.   

Abstract

Monolayers of human peripheral blood polymorphonuclear neutrophils and 14C-labeled Staphylococcus aureus were incubated at various temperatures. The rate and extent of phagocytosis was unchanged between 33 and 41 C but was depressed above and below this range

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1140851      PMCID: PMC415270          DOI: 10.1128/iai.12.1.221-223.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  Intraleukocytic bacteria in endocarditis patients.

Authors:  D L Powers; G L Mandell
Journal:  JAMA       Date:  1974-01-21       Impact factor: 56.272

2.  Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy.

Authors:  G L Mandell; E W Hook
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965

3.  Direct measurement of leukocyte motility: effects of pH and temperature.

Authors:  G G Nahas; M L Tannieres; J F Lennon
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

4.  Polymorphonuclear leukocyte motility in vitro. I. Effect of pH, temperature, ethyl alcohol, and caffeine, using a modified Boyden chamber technic.

Authors:  P Phelps; D Stanislaw
Journal:  Arthritis Rheum       Date:  1969-06

5.  Measurement of rates of phagocytosis: the use of cellular monolayers.

Authors:  R H Michell; S J Pancake; J Noseworthy; M L Karnovsky
Journal:  J Cell Biol       Date:  1969-01       Impact factor: 10.539

6.  Studies on human leukocyte motility. I. Effects of alterations in pH, electrolyte concentration, and phagocytosis on leukocyte migration, adhesiveness, and aggregation.

Authors:  R E Bryant; R M DesPrez; M H VanWay; D E Rogers
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

  6 in total
  16 in total

1.  Effect of temperature on bacterial killing by serum and by polymorphonuclear leukocytes.

Authors:  J Sebag; W P Reed; R C Williams
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

2.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

3.  Phagocytosis induced by yeast cells in canine granulocytes: a methodological study.

Authors:  G Trowald-Wigh; K Thorén-Tolling
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

4.  Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; I Dubbeldeman-Rempt; R van Furth
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

5.  Strain specificity of opsonins for group B streptococci types II and III.

Authors:  A O Shigeoka; R T Hall; H R Hill
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 6.  Temperature and host defense.

Authors:  N J Roberts
Journal:  Microbiol Rev       Date:  1979-06

7.  Influence of temperature on opsonization and phagocytosis of staphylococci.

Authors:  P K Peterson; J Verhoef; P G Quie
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Gonococci-human polymorphonuclear leukocyte interactions: metabolic studies associated with attachment and ingestion.

Authors:  A G Krieger; N L Schiller; R B Roberts
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Effects of hyperthermia on phagocytosis and intracellular killing of Sporothrix schenckii by polymorphonuclear leukocytes.

Authors:  M Hiruma; S Kagawa
Journal:  Mycopathologia       Date:  1986-08       Impact factor: 2.574

10.  Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.